01 1ALFUZOSIN HYDROCHLORIDE
02 5CEFDINIR
03 1CEFPODOXIME PROXETIL
04 1DYANAVEL XR
05 1DYANAVEL XR 10
06 1DYANAVEL XR 15
07 1DYANAVEL XR 20
08 1DYANAVEL XR 5
09 1ILEVRO
10 2LISDEXAMFETAMINE DIMESYLATE
11 1METHYLIN
12 1OLANZAPINE
13 1QUILLICHEW ER
14 2RISPERIDONE
01 121475
02 165259
03 165332
04 165337
05 165429
06 165473
07 177328
08 178464
09 190031
10 190284
11 1202285
12 1203491
13 1207960
14 1208147
15 4210526
16 1214134
17 1214484
01 13No
02 7Yes
Drug : CEFDINIR
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 65473
Country : US
Patented : No
Drug : CEFDINIR
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 65337
Country : US
Patented : No
Drug : CEFPODOXIME PROXETIL
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 90031
Country : US
Patented : No
Drug : ALFUZOSIN HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 90284
Country : US
Patented : No
Drug : CEFDINIR
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 65259
Country : US
Patented : No
Drug : METHYLIN
Dosage Form : TABLET, CHEWABLE; ORAL
Application Number : 21475
Country : US
Patented : No
Drug : RISPERIDONE
Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL
Application Number : 78464
Country : US
Patented : No
Drug : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : TABLET, CHEWABLE; ORAL
Application Number : 214134
Country : US
Patented : No
Drug : OLANZAPINE
Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL
Application Number : 202285
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
